Group | Median TAS (IQR) | Mean TAS (SD) | p value |
---|
EPO therapy | 8 (7–10) | 7.84 (2.25) | 0.013 |
No EPO therapy | 9 (7–11) | 9.15 (2.45) | |
- Median and mean activity loss scores were calculated for patients currently receiving EPO therapy for their CKD-induced anaemia and compared to those who did not require EPO therapy